China R&D

Quintiles, a US-based biopharma services company offering clinical, commercial, consulting and capital solutions, has expanded its data management services to Shanghai, China. Quintiles has opened its first office in the region in 1993. Quintiles will closely work with its biostatistics and medical writing teams in China to accommodate customer demand for increased efficiencies through integrated [...]

July 30 (Bloomberg) — Charles River Laboratories International Inc. withdrew a $1.6 billion bid for WuXi PharmaTech (Cayman) Inc., citing investor opposition to what would have been the largest foreign takeover of a China company. Charles River said today it will pay WuXi a $30 million break fee after the companies agreed to end the [...]

CRO Icon has opened a 3,000 sq ft central laboratory in Tianjin, China in partnership with Fountain Medical Development (FMD). Icon now operates three central laboratories in Asia Pacific, with the Tianjin site joining existing facilities in Bangalore, India and Singapore. Establishing a central laboratory in China will bring the contract research organisation (CRO) closer [...]

(RTTNews) - Clinical research organization ReSearch Pharmaceutical Services Inc (RPSE) filed with the U.S. Securities and Exchange Commission on Friday to raise up to $100 million in an initial public offering of common stock. In its filing, the provider of trial management services to the biopharmaceutical industry did not reveal how many shares the company and [...]

WASHINGTON — Medical ethicists have worried for years about the growing share of new drugs whose human trials took place in foreign countries where federal auditors could not make sure patients were protected, but no one knew how big the potential problem was. But according to a report by Daniel R. Levinson, the inspector general [...]

BASKING RIDGE, N.J., & SHANGHAI, CHINA , May 19, 2010 – i3, a global life sciences services company and subsidiary of Ingenix, has acquired ChinaGate, a contract research organization (CRO) that provides product-development regulatory services for pharmaceutical, medical device and biotechnology companies looking to enter and access the Chinese market. ChinaGate has successfully guided customers [...]

Parexel International, a US-based provider of biopharmaceutical services, has opened offices in Chengdu and Guangzhou to support a growing requirement for a range of clinical development and regulatory consulting capabilities in China and throughout the Asia/Pacific region. The locations further expand Parexel’s presence in China, which includes offices in Beijing and Shanghai as well as [...]

CINCINNATI, OH–(Marketwire – May 6, 2010) –  Medpace Reference Laboratories LLC (MRL), a Medpace company, announced today that its new laboratories in Beijing, China and Mumbai, India have achieved accreditation by the College of American Pathologists (CAP), NGSP Level 1 and CDC Lipid Standardization (LSP) Part III. They complement laboratories in Leuven, Belgium and Cincinnati, [...]

PPD has opened a vaccine clinical research center in Taizhou, China. Through the center, PPD will provide clinical-monitoring services to global and local biopharmaceutical companies seeking to develop vaccines in China. Located at the Taizhou China Medical City, the center will help biopharmaceutical companies address unique requirements for conducting vaccine clinical trials in the country. [...]

Charles River Laboratories International, Inc. (NYSE: CRL), a leading global provider of research models and associated services and of preclinical drug development services, and WuXi PharmaTech (Cayman) Inc. (NYSE: WX), a leading drug research and development outsourcing company with expertise in discovery chemistry and with operations in China and the United States, today announced that [...]